Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

In 2017, Spanish dermatologists commonly prescribed topical minoxidil, oral finasteride, and nutricosmetics for hair loss, with oral contraceptives also used for premenopausal women. Less common were oral dutasteride, due to side effects, and newer, more expensive treatments like topical finasteride and Low-Level Laser Therapy. The conclusion is that there's a need for prescription guidelines due to varied treatment approaches.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Methotrexate may help stabilize frontal fibrosing alopecia.

Familial frontal fibrosing alopecia is rare, mostly affects women, and often occurs between sisters or mother-daughter pairs.

Strontium ranelate is no longer available for treatment.

Over-the-counter products can help with menopause symptoms, but be aware of their ingredients.

Trichoscopy is useful for diagnosing Frontal Fibrosing Alopecia.

Combination of minoxidil and finasteride is more effective in increasing hair diameter than minoxidil alone for female-pattern hair loss.

Dermoscopy helps diagnose frontal fibrosing alopecia by identifying specific scalp features.

Androgenetic alopecia can be treated with minoxidil and finasteride, requiring long-term use and patient cooperation.

Effective treatment guidelines for frontal fibrosing alopecia are still unclear.

Early treatment and multidisciplinary care are key to managing Frontal Fibrosing Alopecia and preventing further hair loss.

A young man with an unusual type of scarring hair loss suggests a possible new variant of a known scalp condition.

A rare ovarian tumor that produced testosterone caused a blood clot in the lungs and increased red blood cells in a woman.

The conclusion is that managing hair loss conditions like FFA and melanoma requires individualized approaches, considering new findings and balancing treatment benefits with potential risks.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

Frontal fibrosing alopecia and ulerythema ophryogenes may be related and can evolve from one to the other.

The higher dose supplement was more effective in treating female hair loss.

Using GnRHa agonists helps diagnose and treat ovarian hyperthecosis when surgery isn't possible.

A 66-year-old woman experienced hair loss due to Frontal Fibrosing Alopecia, a condition with no consistently effective treatment, but it usually stabilizes over time. More research is needed for better understanding and treatment options.

Monitoring for adverse effects in clinical treatments is crucial.

Hair and nail conditions can stabilize or improve over time, and new treatments show promise.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Iron deficiency may be related to hair loss, but there's not enough evidence to recommend iron screening or supplements for all hair loss patients.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

Female pattern hair loss can be treated with medications, surgery, and cosmetic products, considering its psychological impact.

Women have unique stroke risks due to hormones, contraceptives, pregnancy, and menopause.